Package 16729-443-10

{"route": ["ORAL"], "spl_id": "4092a3ea-403d-7a91-e063-6394a90a8ddf", "openfda": {"upc": ["0316729444101", "0316729443104"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["34686e9d-c106-4276-8b47-7460cca8860e"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-10)", "package_ndc": "16729-443-10", "marketing_start_date": "20181108"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-15)", "package_ndc": "16729-443-15", "marketing_start_date": "20181108"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-443-16)", "package_ndc": "16729-443-16", "marketing_start_date": "20181108"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "16729-443_4092a3ea-403d-7a91-e063-6394a90a8ddf", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "16729-443", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20181108", "listing_expiration_date": "20261231"}